arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2210.07247q-bio.BM
收藏

新冠疫情期间核酸疫苗的成熟发展

The Coming of Age of Nucleic Acid Vaccines during COVID-19

Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta Naik, Jeremy P. Kamil, COVID-19 Review Consortium, Antho… 展开作者

Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta Naik, Jeremy P. Kamil, COVID-19 Review Consortium, Anthony Gitter, Casey S. Greene

AI总结:

该研究梳理了核酸疫苗的发展背景,介绍了新冠疫情中DNA/RNA疫苗的有效性、安全性与获批情况及全球分发模式,指出其快速研发标志着疫苗技术的重大转变,开启了新发病原体疫苗研发的新时代。

摘要:

21世纪以来,多种新发病毒已构成全球威胁,每一种病原体都凸显了快速、可规模化疫苗开发项目的价值。当前的SARS-CoV-2大流行让这类工作的重要性体现得尤为明显。疫苗学领域的新生物技术进展催生了最新成果:这类疫苗仅提供抗原的核酸构建模块,消除了诸多安全隐患。在COVID-19大流行期间,这些DNA和RNA疫苗以前所未有的速度推动了疫苗的研发与部署。这一成功至少部分归因于相较于以往流行病,科学研究领域发生了更广泛的转变:SARS-CoV-2的基因组早在2020年1月就已公布,在国际社会意识到这一新病毒威胁后的两周内,就为全球DNA和RNA疫苗的研发工作提供了助力。此外,这些此前仅停留在理论层面的技术不仅安全,而且有效性极高。尽管疫苗开发在历史上是一个缓慢的过程,但COVID-19危机期间疫苗的快速研发揭示了疫苗技术的重大转变。本文为这些颠覆性疫苗的出现提供了历史背景,介绍了多种DNA和RNA疫苗的有效性、安全性及获批状态,还讨论了全球范围内的分发模式。2020年初以来取得的进展极佳地证明了疫苗开发技术在过去二十年里的飞速发展,也预示着针对新发病原体的疫苗研发进入了一个新时代。

英文摘要:

In the 21st century, several emergent viruses have posed a global threat. Each pathogen has emphasized the value of rapid and scalable vaccine development programs. The ongoing SARS-CoV-2 pandemic has made the importance of such efforts especially clear. New biotechnological advances in vaccinology allow for recent advances that provide only the nucleic acid building blocks of an antigen, eliminating many safety concerns. During the COVID-19 pandemic, these DNA and RNA vaccines have facilitated the development and deployment of vaccines at an unprecedented pace. This success was attributable at least in part to broader shifts in scientific research relative to prior epidemics; the genome of SARS-CoV-2 was available as early as January 2020, facilitating global efforts in the development of DNA and RNA vaccines within two weeks of the international community becoming aware of the new viral threat. Additionally, these technologies that were previously only theoretical are not only safe but also highly efficacious. Although historically a slow process, the rapid development of vaccines during the COVID-19 crisis reveals a major shift in vaccine technologies. Here, we provide historical context for the emergence of these paradigm-shifting vaccines. We describe several DNA and RNA vaccines and in terms of their efficacy, safety, and approval status. We also discuss patterns in worldwide distribution. The advances made since early 2020 provide an exceptional illustration of how rapidly vaccine development technology has advanced in the last two decades in particular and suggest a new era in vaccines against emerging pathogens.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑